• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 29 of 100
Colorado lawmakers wage multi-front assault on high drug costs
HealthColorado lawmakers wage multi-front assault on high drug costs
By Markian Hawryluk and Kaiser Health NewsMay 24, 2021
AbbVie drug price hikes
HealthWill AbbVie, maker of the world’s best-selling drug, finally face the music over its price hikes?
By Sy MukherjeeMay 19, 2021
Making cancer treatments affordable today won’t hurt tomorrow’s innovation
CommentaryMaking cancer treatments affordable today won’t hurt tomorrow’s innovation
By Rena Conti, Richard Frank and Leslie DachMay 12, 2021
Independent pharmacies are fighting to stay in business through the pandemic
HealthIndependent pharmacies are fighting to stay in business through the pandemic
By Markian Hawryluk and Kaiser Health NewsApril 29, 2021
GoodRx helps people afford drugs. But is it improving health care or profiting off a broken system?
FeaturesGoodRx helps people afford drugs. But is it improving health care or profiting off a broken system?
By Erika FryApril 29, 2021
Brainstorm Health 2021-Moderna-Stephane Bancel
ConferencesModerna is working toward a single shot for both COVID and flu protection
By Sy MukherjeeApril 27, 2021
One billion COVID vaccines
NewslettersWould a free water bottle convince you to get a COVID vaccine?
By Sy MukherjeeApril 26, 2021
One billion COVID vaccines
NewslettersThe last mile of the immunization campaign approaches
By Sy Mukherjee and David Z. MorrisApril 23, 2021
Skeptical of outdoor masking? Congratulations on catching up to reality.
NewslettersSkeptical of outdoor masking? Congratulations on catching up to reality.
By Sy Mukherjee and David Z. MorrisApril 22, 2021
The last mile of the immunization campaign approaches
NewslettersThe last mile of the immunization campaign approaches
By Sy Mukherjee and David Z. MorrisApril 21, 2021
What’s the matter with Michigan?
NewslettersWhat’s the matter with Michigan?
By Sy Mukherjee and David Z. MorrisApril 20, 2021
A milestone for COVID vaccinations as all U.S. adults are eligible
NewslettersA milestone for COVID vaccinations as all U.S. adults are eligible
By Sy Mukherjee and David Z. MorrisApril 19, 2021
Drug development innovation
NewslettersWhat makes a drug company truly innovative?
By Sy Mukherjee and David Z. MorrisApril 16, 2021
Johnson and Johnson covid vaccine
HealthPublic confidence in the Johnson & Johnson vaccine has dropped. What will it take to restore trust?
By Sy MukherjeeApril 16, 2021
Meet the most innovative and inventive pharmaceutical companies of 2021
HealthMeet the most innovative and inventive pharmaceutical companies of 2021
By Sy Mukherjee and IDEA PharmaApril 16, 2021
1...
  • 27
  • 28
  • 29
  • 30
  • 31
...100
Most Popular
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethicplaceholder alt text
By Orianna Rosa RoyleJune 24, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Retail
Amazon's record Prime Day masks a darker truth: Americans are spending more and getting lessplaceholder alt text
By Nick LichtenbergJune 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.